Safety and Efficacy Study of TPI-287 in Neuroblastoma and Medulloblastoma

This study is ongoing, but not recruiting participants.
Sponsor:
Collaborators:
Van Andel Research Institute
Cortice Biosciences, Inc.
Information provided by (Responsible Party):
Giselle Sholler, Spectrum Health Hospitals
ClinicalTrials.gov Identifier:
NCT01483820
First received: November 28, 2011
Last updated: March 10, 2015
Last verified: March 2015
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is ongoing, but not recruiting participants.
  Estimated Study Completion Date: November 2018
  Estimated Primary Completion Date: November 2015 (Final data collection date for primary outcome measure)